The China Laparoscopic Right Hemicolectomy SNAPSHOT

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04628182

Enrollment

1579

Registered

2020-11-13

Start date

2021-09-01

Completion date

2022-06-30

Last updated

2022-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Right Hemicolectomy

Brief summary

The main objective is to explore the current practice of right hemicolectomy for colon cancer located in the ascending colon and hepatic flexure in selected Chinese high quality and high volume centres. This study will identify a potential area to improve the level of standard care and serve as a reference cohort to which planned standardization and addition of innovative aspects can be compared to

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Segmental right sided hemicolectomy (including extended) * Cancer stage 1-3 (CT-staged) * No prior abdominal surgery

Exclusion criteria

* Stage cT4b, perforated disease * Acute obstruction * Emergency surgery * Right hemicolectomy or ileocaecal resection as part of a large procedure such as subtotal colectomy or panproctocolectomy * Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)

Design outcomes

Primary

Measure	Time frame	Description
post-operative anastomotic leakages	1 month	Number of post-operative anastomotic leakages within 30 days.

Countries

China

Outcome results